Navigation Links
Biopharma Leaders Unite to Share Real-Life Business Development Experiences at LeadingBiotech’s Boston BD Conference
Date:7/26/2019

LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston BD conference to be held on September 10, 2019, at the Westin Boston Waterfront Hotel. As part of Biotech Week Boston, the event provides an opportunity for attendees to leverage insight from real-life business development experiences, network with biopharma executives and share insights on the business challenges and opportunities impacting the industry.

"It’s a great conference to meet like-minded people working in the same space. Excellent for networking and thought-provoking discussion," commented Lesley Solomon, SVP Innovation, Chief Innovation Officer, Dana-Farber Cancer Institute, and a speaker at this year’s event.

Key topics at this year’s conference include Improving Patients Lives & Re-Defining Value, Pioneering New Business Models for Creative Deal Structures, and a fireside chat on True Collaborations Between Companies.

Keynote speakers at the conference include:

  • Mary Lynne Hedley, Ph.D., President and COO, TESARO
  • Jeb Keiper, M.S., M.B.A., CEO, Nimbus Therapeutics
  • David K. Lee, CEO, Servier Pharmaceuticals
  • Lonnie Moulder, Founding General Partner, Tellus BioVentures and Venture Advisor, NEA
  • Praveen Tipirneni, President and CEO, Morphic Therapeutics
  • James Tobin, Ph.D., Vice President, Cardiovascular and Metabolic Scientific Innovation, Johnson & Johnson Innovation?

Other new speakers include

  • Kerrie Brady, BPharm, M.S., M.B.A.,?CBO & EVP, Corporate Strategy,?Centrexion?Therapeutics?
  • Michelle Doig, Partner, Omega Funds
  • Elcin Ergun, M.B.A., EVP, President New Business, EMD Serono
  • Bill Geary, Co-Founder & General Partner, Flare Capital Partners
  • Sophie Kornowski, Senior Partner, Gurnet Point Capital
  • Reenie McCarthy, CEO,?Stealth?BioTherapeutics
  • Ronald Renaud, CEO, Translate Bio
  • Lesley Solomon, SVP Innovation, Chief Innovation Officer, Dana-Farber Cancer Institute
  • Alex Waldron, Chief Strategy Officer, Pear Therapeutics

Save $400 with the early bird rate if you register before August 1. Reserve your spot now.

Nominate a Rising Star in the Biopharma Community:
New this year, LeadingBiotech is accepting nominations for a Rising Star, an experienced executive who is an up-and-coming mover and shaker in the biopharma community. Nominations are being accepted through August 15, 2019. The elected Rising Star will receive a complimentary pass to Boston BD. Nominate someone for this recognition here.

About LeadingBiotech
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.

Read the full story at https://www.prweb.com/releases/biopharma_leaders_unite_to_share_real_life_business_development_experiences_at_leadingbiotechs_boston_bd_conference/prweb16463525.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Heavily Featured in Recent Documentary About Regenerative Medicine for Domestic and Wild Animals
2. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
3. VetStem Biopharma Shares the Story of Atlas Who Was Successfully Treated with VetStem Cell Therapy by Dr. Colter Negranti
4. VetStem Biopharma Shares the Success Story of Frank who was Treated with VetStem Cell Therapy by Pain Management Specialist Dr. Jamie Gaynor
5. VetStem Biopharma Shares the Story of Sonny Bar Lisa Who Was Successfully Treated With VetStem Cell Therapy
6. LeadingBiotech’s Boston CEO Conference Unites Biopharma Leaders May 28-29 at Four Seasons Hotel
7. VetStem Biopharma is Pleased to Share the Success Story of Bogey Who Was Treated with VetStem Cell Therapy by Dr. Ava DeCozio
8. VetStem Biopharma Shares the Story of San Fransisko Who Advanced in His Dressage Career After Being Treated with VetStem Cell Therapy
9. VetStem Biopharma Launches Human Stem Cell Company in San Diego
10. VetStem Biopharma is Pleased to Announce Dr. Douglas Stramel of Advanced Care Veterinary Services is Successfully Using the Pall V-PET™ Platelet Therapy System
11. VetStem Biopharma is Pleased to Share the Success Story of Rascal who was Treated with VetStem Cell Therapy by Dr. Deborah Fegan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... 2019 , ... As Keck Graduate Institute (KGI) students completing ... with a set of recommendations to enhance supply chain processes. Now the 2019 ... to a wider audience of industry leaders attending the 12th Annual Bio Supply ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... a new life sciences leadership firm that is enabling clinical program outsourcing success ... , Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 edition ... , is now available online on the company’s global website. The Bridge features ... diffraction, fluorescence and imaging, and presents articles, scientific papers and news reports. ...
(Date:9/24/2019)... ... , ... The Grain Foods Foundation is excited to announce ... Holscher is an Assistant Professor of Nutrition in the Department of Food Science ... Illinois Urbana-Champaign, where she has affiliate appointments with the Institute of Genomic Biology ...
Breaking Biology Technology:
(Date:9/25/2019)... ... September 25, 2019 , ... ... have placed over 20,000 dental implants for a variety of procedures, including single ... and pterygoid dental implants. Dental implants offer patients permanent tooth replacement ...
(Date:9/24/2019)... ... September 23, 2019 , ... Global ... announce today that Holotype HLA and other Omixon products will be featured among ... American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, PA. Omixon’s Lunch ...
(Date:9/22/2019)... ANGELES (PRWEB) , ... September 20, 2019 , ... ... that instrument makers are adjusting to client demands for precision medicine products. The ... with demand exceeding $19 billion in 2018, the pharma/bio sector is the largest ...
Breaking Biology News(10 mins):